News

News Archive

Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019 Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019

Mogrify platform recognized as having potential to transform future development of new medicines at prestigious awards ceremony. Mogrify Chair receives Lifetime Achievement Award for contributions to biologics discovery and development

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina

The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued commitment to the topical and transdermal market.

Horizon Discovery partners with the Human Protein Atlas Horizon Discovery partners with the Human Protein Atlas

Horizon’s HAP1 cell line to be integrated in the HPA Cell Atlas program. Knockout cell models from Horizon chosen based on consistency and reproducibility demonstrated in validation studies. Agreement will expand open access resource, supporting genetic research globally

SparingVision wins First Prize at EIT European Health Catapult competition SparingVision wins First Prize at EIT European Health Catapult competition

SparingVision awarded First Prize in the Biotech category during the European EIT Health Summit held in Paris from 2 to 3 December

LUNAC Therapeutics led project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant LUNAC Therapeutics led project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant

18 month project in collaboration with University of Leeds and Medicines Discovery Catapult will deliver a new compound for treatment of thrombosis. Currently available anticoagulants carry high risk of bleeding

RB confirms £200m UK investment commitment including new Science & Innovation Centre RB confirms £200m UK investment commitment including new Science & Innovation Centre

Hull, UK, 3rd December 2019 - RB plc, the leading global consumer health, hygiene and home company, today opens its state-of-the-art Science and Innovation Centre (“S&I Centre”) in Hull.

René Medema appointed new chair of EU-LIFE René Medema appointed new chair of EU-LIFE

Professor René Medema, Director of Research of the Netherlands Cancer Institute, has been appointed the new chair of EU-LIFE, an alliance of thirteen leading life science institutes in Europe, as of 1 January 2020.